<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05024500</url>
  </required_header>
  <id_info>
    <org_study_id>COVIDPTcare</org_study_id>
    <nct_id>NCT05024500</nct_id>
  </id_info>
  <brief_title>Clinical and Functional Outcomes of Critically Ill Patients With COVID-19</brief_title>
  <acronym>COVIDPTcare</acronym>
  <official_title>Clinical, Respiratory, Peripheral, Muscle and Functionality Outcomes of Adult ICU Inpatients and Rehabilitation-center Outpatients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal de Pernambuco/PROPESQI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CAPES CODE 001</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CNPq (GRANT 403341/2020-5)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FACEPE (APQ-0249-4.08/20)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People affected by Severe Acute Respiratory Syndrome (SARS) by COVID-19 virus my require a&#xD;
      long lasting invasive mechanical ventilation life support. To prevent damages to the lungs a&#xD;
      number of protective lung ventilation measures are taken, one of them encounters the positive&#xD;
      end expiratory pressure (PEEP) titration. Up to date, it is unclear the best method to&#xD;
      titrate PEEP considering this unconventional syndrome compared to other etiologies. In&#xD;
      addition to the long lasting advanced life support and bedridden condition, other factors may&#xD;
      affect respiratory and peripheral muscle function of these patients. Therefore, the&#xD;
      investigators intend to follow up these patients randomized to one of the three-arm&#xD;
      experimental PEEP titration and after ICU discharge their status on clinical, laboratory and&#xD;
      physical functions assessments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory&#xD;
      Syndrome - Coronavirus-2 (SARS-CoV-2) requires mechanical ventilatory (MV) life support. In&#xD;
      this scenario, lung protective strategies have been recommended for avoiding ventilator&#xD;
      induced lung injuries mainly by inappropriate positive end expiratory pressure (PEEP)&#xD;
      titration. However, the best method of PEEP titration for these patients remains unclear,&#xD;
      since its clinical and morphofunctional phenotype may differ from the conventional acute&#xD;
      respiratory distress syndrome (ARDS) phenotype resulted from other etiologies. In addition,&#xD;
      these patients' condition of long lasting MV dependency and bed restriction may lead to&#xD;
      deterioration of respiratory and peripheral muscles functions.&#xD;
&#xD;
      Objective: To compare the clinical and laboratory evolution and the respiratory and&#xD;
      peripheral muscle functions in mechanically ventilated patients with COVID-19 submitted to&#xD;
      PEEP titration by the following methods: ARDSNet protocol, driving pressure (DP) and&#xD;
      electrical impedance tomography (EIT), as well as following them up after hospital discharge.&#xD;
&#xD;
      Methods: This is a controlled, randomized, double blind clinical trial with 90 mechanically&#xD;
      ventilated patients to be randomized in one of the 3 PEEP titration- related groups: ARDSNet&#xD;
      protocol, Driving Pressure-DP (electing PEEP level by the lowest DP) and by the EIT (PEEP&#xD;
      selected will be the closest level above the intercept point of cumulated collapse and&#xD;
      overdistension percentage curves). Clinical, laboratory, oxygenation, ventilation,&#xD;
      respiratory and regional mechanics data, as well as peripheral muscle outcomes (strength and&#xD;
      functionality) will be monitored from intubation to extubation in the supine and prone&#xD;
      position. The outcomes of respiratory and peripheral muscles functionality will be monitored&#xD;
      for six months after hospital discharge. All ethical principles will be respected with either&#xD;
      written Free and Consent Term by the patient or relatives at the intensive care phase or at&#xD;
      the post ICU discharge phase. Data will be registered for posterior analysis, which considers&#xD;
      the difference between groups with p &lt;0.05.&#xD;
&#xD;
      Expected results: Based on this study, it is expected to identify the Peep titration method&#xD;
      associated to the greater beneficial and less deleterious effects in critically ill patients&#xD;
      on MV. Also to address appropriate lung protective ventilation strategy for these patients&#xD;
      and to detect respiratory and peripheral muscle disorders as early as possible in critically&#xD;
      ill survivors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2021</start_date>
  <completion_date type="Anticipated">July 11, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 11, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>three groups of treatments (A, B and C) are given so that one group receives only A while another group receives only B and the third group receives only C. All volunteers will be randomized to one of the three groups of treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>trial participants, data collectors and outcome assessors or committees will remain blinded to the patient assigned group of treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Murray Score (LIS)</measure>
    <time_frame>4 hours</time_frame>
    <description>Scoring system for lung injury including hypoxemia, respiratory system compliance, chest radiographic findings and level of PEEP. The minimum value is zero and the maximum value is sixteen. The higher the score the worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Potential lung recruitment measured during electrical impedance tomography</measure>
    <time_frame>4 hours</time_frame>
    <description>to quantify lung ventilation distribution</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of days in intensive care unit (ICU days)</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to quantify the number of days spent in a critical care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work of breathing (WOB) measured during surface electromyography</measure>
    <time_frame>4 hours</time_frame>
    <description>measured in root-mean-squared electromyography signals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation (MV days)</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to quantity the number of days with use of invasive mechanical ventilation in inpatients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Mortality</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to quantify number of living days between ICU admission and deceased status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory muscle strength</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>maximal static respiratory mouth pressures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced vital capacity (FVC) measured during spirometry</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>measures obtained by spirometry in outpatients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragmatic mobility measured during ultrasonography</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>diaphragmatic excursion expressed in millimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragmatic thickening measured during ultrasonography</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>diaphragmatic thickening expressed in millimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>breathing pattern measured during airway flowmeter</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>a device to quantify airway flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral muscle strength I</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to be evaluated by Medical Research Council's scale. The minimum score is 0 and the maximum is 60. The higher the score, the better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral muscle strength II</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to be evaluated by a handgrip dynamometers in outpatients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral muscle strength III</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to be evaluated by a handheld dynamometer in outpatients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>six-minute walk test (6WT)</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>sub-maximal exercise test used to assess aerobic capacity and endurance in outpatients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional capacity (Perme scale)</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>The minimum score is 0 and the maximum is 32. The higher the score, the better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>daily activities performance</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>to be evaluated by Barthel Index in outpatients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life measured by Short Form Health survey 36</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Acute Respiratory Distress Syndrome (ARDS)</condition>
  <arm_group>
    <arm_group_label>ADRSNet protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ARDSnet protocol is the current, standard of care for ARDS. Its used by setting PEEP and the fraction of inspired oxygen (FiO2) to achieve the oxygenation goal (SpO2 ≥ 93% - accepting the range of 90-96%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Driving Pressure (DP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>setting PEEP after performing a modified alveolar recruitment maneuver followed by a decremental PEEP titration electing the level correspondent to the lowest driving pressure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrical Impedance Tomography (EIT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After performing a modified alveolar recruitment maneuver, the PEEP decremental titration guided by the EIT will be set at the level above the intersection of the curves representing relative alveolar overdistention and collapse.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ARDSNet table</intervention_name>
    <description>The setting of the lowest PEEP level and FiO2 match stated by the table to achieve a goal oxygenation.</description>
    <arm_group_label>ADRSNet protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Driving Pressure</intervention_name>
    <description>The setting of the lowest PEEP level by the lowest correspondent driving pressure, which is defined by the difference of plateau pressure, after a modified alveolar recruitment maneuver.</description>
    <arm_group_label>Driving Pressure (DP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electrical Impedance Tomography</intervention_name>
    <description>The setting of the PEEP level above the intersection of the curves representing relative alveolar overdistention and collapse, after a modified alveolar recruitment maneuver.</description>
    <arm_group_label>Electrical Impedance Tomography (EIT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  mechanically ventilated patients due to acute respiratory failure associated to&#xD;
             COVID-19 confirmed or suspected cases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  consent refusal by patient, family or doctor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shirley Lima Campos, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Federal de Pernambuco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shirley Lima Campos, PhD</last_name>
    <phone>+5581999413087</phone>
    <email>shirley.campos@ufpe.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wagner S Souza Leite, MSc</last_name>
    <phone>+5581982442798</phone>
    <email>wagnerszleite@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital das Clinicas - UFPE</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50670-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Gonçalves de Albuquerque, MSc</last_name>
      <phone>+5581992347913</phone>
    </contact>
    <investigator>
      <last_name>Fabianne Maísa de N Assis Dantas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudio Gonçalves de Albuquerque</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alita Paula Lopes de Novaes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wagner Souza Leite</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physical Therapy Department, Universidade Federal de Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50670-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armele Dornelas de Andrade, PhD</last_name>
      <phone>+5581987818965</phone>
      <email>armele.andrade@ufpe.br</email>
    </contact>
    <investigator>
      <last_name>Daniella Cunha Brandão, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jakson Henrique Silva</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital da Mulher do Recife</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50790-640</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Eduardo Santos Rego Barros, MSc</last_name>
      <phone>+5581999177440</phone>
      <email>carlosregobarros@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Geral Otavio de Freitas</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50920-460</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thayse Neves Santos Silva, MSc</last_name>
      <phone>+5581991115993</phone>
    </contact>
    <investigator>
      <last_name>Luciana Alcoforado Mendes Silva</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romulo de Aquino Coelho Lins</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Alfredo Ramirez Gonzalez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thayse Neves Santos Silva</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raiana Luciola Castro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dandara Pestana de Souza Oliveira</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, Sun C, Sylvia S, Rozelle S, Raat H, Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x. Review.</citation>
    <PMID>32183901</PMID>
  </reference>
  <reference>
    <citation>Adler A, Arnold JH, Bayford R, Borsic A, Brown B, Dixon P, Faes TJ, Frerichs I, Gagnon H, Gärber Y, Grychtol B, Hahn G, Lionheart WR, Malik A, Patterson RP, Stocks J, Tizzard A, Weiler N, Wolf GK. GREIT: a unified approach to 2D linear EIT reconstruction of lung images. Physiol Meas. 2009 Jun;30(6):S35-55. doi: 10.1088/0967-3334/30/6/S03. Epub 2009 Jun 2.</citation>
    <PMID>19491438</PMID>
  </reference>
  <reference>
    <citation>Beitler JR, Sarge T, Banner-Goodspeed VM, Gong MN, Cook D, Novack V, Loring SH, Talmor D; EPVent-2 Study Group. Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2019 Mar 5;321(9):846-857. doi: 10.1001/jama.2019.0555.</citation>
    <PMID>30776290</PMID>
  </reference>
  <reference>
    <citation>Costa EL, Borges JB, Melo A, Suarez-Sipmann F, Toufen C Jr, Bohm SH, Amato MB. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography. Intensive Care Med. 2009 Jun;35(6):1132-7. doi: 10.1007/s00134-009-1447-y. Epub 2009 Mar 3.</citation>
    <PMID>19255741</PMID>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Frerichs I, Becher T, Weiler N. Electrical impedance tomography imaging of the cardiopulmonary system. Curr Opin Crit Care. 2014 Jun;20(3):323-32. doi: 10.1097/MCC.0000000000000088. Review.</citation>
    <PMID>24739268</PMID>
  </reference>
  <reference>
    <citation>Fumagalli J, Berra L. What does the Acute Respiratory Distress Syndrome trial (ART) teach us?-it is time for precision medicine and precision trials in critical care! J Thorac Dis. 2018 Mar;10(3):1300-1303. doi: 10.21037/jtd.2018.03.31.</citation>
    <PMID>29707281</PMID>
  </reference>
  <reference>
    <citation>Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, Chan KS, Haja Mohideen S. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from Coronavirus Disease 2019 (COVID-19) Infection. Ann Acad Med Singap. 2020 Mar 16;49(3):108-118.</citation>
    <PMID>32200400</PMID>
  </reference>
  <reference>
    <citation>Huh JW, Jung H, Choi HS, Hong SB, Lim CM, Koh Y. Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome. Crit Care. 2009;13(1):R22. doi: 10.1186/cc7725. Epub 2009 Feb 24.</citation>
    <PMID>19239703</PMID>
  </reference>
  <reference>
    <citation>Liu S, Tan L, Möller K, Frerichs I, Yu T, Liu L, Huang Y, Guo F, Xu J, Yang Y, Qiu H, Zhao Z. Identification of regional overdistension, recruitment and cyclic alveolar collapse with electrical impedance tomography in an experimental ARDS model. Crit Care. 2016 May 3;20(1):119. doi: 10.1186/s13054-016-1300-y.</citation>
    <PMID>27142073</PMID>
  </reference>
  <reference>
    <citation>Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720-3. Erratum in: Am Rev Respir Dis 1989 Apr;139(4):1065.</citation>
    <PMID>3202424</PMID>
  </reference>
  <reference>
    <citation>Sahetya SK, Hager DN, Stephens RS, Needham DM, Brower RG. PEEP Titration to Minimize Driving Pressure in Subjects With ARDS: A Prospective Physiological Study. Respir Care. 2020 May;65(5):583-589. doi: 10.4187/respcare.07102. Epub 2019 Nov 26.</citation>
    <PMID>31772068</PMID>
  </reference>
  <reference>
    <citation>Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, Hodgson C, Jones AY, Kho ME, Moses R, Ntoumenopoulos G, Parry SM, Patman S, van der Lee L. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020 Apr;66(2):73-82. doi: 10.1016/j.jphys.2020.03.011. Epub 2020 Mar 30.</citation>
    <PMID>32312646</PMID>
  </reference>
  <reference>
    <citation>Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.</citation>
    <PMID>32139904</PMID>
  </reference>
  <reference>
    <citation>Silveira LTYD, Silva JMD, Tanaka C, Fu C. Decline in functional status after intensive care unit discharge is associated with ICU readmission: a prospective cohort study. Physiotherapy. 2019 Sep;105(3):321-327. doi: 10.1016/j.physio.2018.07.010. Epub 2018 Aug 2.</citation>
    <PMID>30342701</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>Shirley Lima Campos</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>participant characteristics (age, gender)&#xD;
clinical measurements (blood pressure, heart rate)&#xD;
medical history&#xD;
clinical laboratory results&#xD;
images (X-rays)&#xD;
adverse events (hemodynamic and respiratory instability, interruptions)&#xD;
details of randomisation and treatment received</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>end of trial</ipd_time_frame>
    <ipd_access_criteria>individual participant data (IPD) access will be granted by the PI after request review for approval via email. It will be shared with researchers and general public of interest on the subject for descriptive analyses related to our sample medical and clinical characteristics. A committee of researchers will be in charge of discussing the request before approving the access.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

